Mesoblast Ltd Ads (NQ: MESO )

9.710 USD +0.110 (+1.15%)

Streaming Delayed Price Updated: 7:32 PM EST, Mar 1, 2021 Add to My Watchlist

Price and Volume

Volume	1,219
Open	9.600
Bid (Size)	9.720 (3)
Ask (Size)	10.65 (10)
Prev. Close	9.600
Today's Range	9.600 - 9.600
52wk Range	3.120 - 21.28
Shares Outstanding	94,654,444
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Positive Outcomes of First Children Treated With Remestemcel-L for Multisystem Inflammatory Syndrome (MIS-C) and Heart Failure Post-COVID-19 Published in Pediatrics

February 17, 2021

Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chroni

February 10, 2021

Performance

YTD	+14.10%	+14.10%
1 Month	+0.94%	+0.94%
3 Month	-35.65%	-35.65%
6 Month	-49.85%	-49.85%
1 Year	+25.29%	+25.29%

More News

Mesoblast Corporate Update

February 10, 2021

Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020

January 28, 2021

Mesoblast Presents Heart Failure Phase 3 Trial Results at Investor Healthcare Conference

January 11, 2021

12 Health Care Stocks Moving In Thursday's Pre-Market Session

February 11, 2021

Mesoblast Spikes On Positive Cell Therapy Data in Back Pain Study

February 11, 2021

Why Mesoblast Limited Is Rising Today

February 11, 2021

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

February 02, 2021

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

January 12, 2021

Mid-Afternoon Market Update: Dow Falls 100 Points; GeoVax Labs Shares Spike Higher

January 11, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.